Pharmaceuticals
Takeda to sell OTC drug unit to Blackstone for $2.3bn
Japanese pharmaceutical maker in bid to reduce debt inflated by Shire purchase
Japanese pharmaceutical maker in bid to reduce debt inflated by Shire purchase
Thai energy conglomerate also eyes Taiwanese company to ramp up capacity
Tech group is working with investors in effort to outbid Microsoft after Trump divestment order
Private equity fund clinches $1.2bn deal for aged-care facility operator
Production will fulfill order from British government for 60m doses
South Korean agency Big Hit eyes multibillion dollar valuation
Deal opens up growth in European and Russian markets
Entrepreneur bought 8% of United Arrows and 6% of Adastria
Company's restructure now in doubt as COVID pandemic continues to bite
Startups seek more than $5bn before stricter auditing rules take effect
Japanese convenience store operator counts on trading house Itochu for comeback
Asiana deal in danger as Jeju Air cancels Eastar Jet purchase
Indebted developer has five-year goal to become largest maker of electric vehicles
Acquisition cements Seven & i's top position in major retail market
Japan's Seven & i to add 4,000 outlets, but shares plunge 8%
Tech investor keeps IPO option and weighs Nvidia investment
Joint investment with co-op aims to widen retail channels for agri sector
Masayoshi Son's tech group weighs options for chip designer, including IPO
The Japanese companies aim to compete against Chinese and South Korean rivals
Century-old company raises $100m from Chinese e-commerce operator
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.